Reliance Industries' Oil-to-Chemicals segment faced margin pressures in the March quarter due to rising crude premiums, ...
Analyst Insight: Many biotech firms struggle to manage the order-to-cash (O2C) cycle effectively because large contract manufacturers (CMOs) often handle physical shipping, while the firm retains ...
JPMorgan maintains an Overweight rating on Reliance Industries. The brokerage sees comfortable relative valuation for RIL.